Wasatch Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-241,295
| Closed | -$11.5M | – | 274 |
|
|
2022
Q3 | $11.5M | Sell |
241,295
-266
| -0.1% | -$14.6K | 0.08% | 163 |
|
|
2022
Q2 | $14.3M | Sell |
241,561
-10,631
| -4% | -$873K | 0.09% | 149 |
|
|
2022
Q1 | $29.3M | Sell |
252,192
-87,230
| -26% | -$10.2M | 0.14% | 125 |
|
|
2021
Q4 | $51.1M | Sell |
339,422
-52,879
| -13% | -$7.14M | 0.21% | 106 |
|
|
2021
Q3 | $46.8M | Buy |
392,301
+26,518
| +7% | +$2.92M | 0.19% | 115 |
|
|
2021
Q2 | $35.6M | Buy |
365,783
+814
| +0.2% | +$72.6K | 0.14% | 135 |
|
|
2021
Q1 | $32.2M | Buy |
364,969
+108,829
| +42% | +$10.1M | 0.14% | 126 |
|
|
2020
Q4 | $24.5M | Sell |
256,140
-19,517
| -7% | -$2.01M | 0.12% | 132 |
|
|
2020
Q3 | $31.3M | Sell |
275,657
-19,645
| -7% | -$2.06M | 0.2% | 111 |
|
|
2020
Q2 | $29.2M | Sell |
295,302
-47,475
| -14% | -$3.79M | 0.21% | 109 |
|
|
2020
Q1 | $22.1M | Sell |
342,777
-17,724
| -5% | -$1.24M | 0.23% | 90 |
|
|
2019
Q4 | $21.5M | Buy |
360,501
+69,988
| +24% | +$4.32M | 0.18% | 108 |
|
|
2019
Q3 | $17.1M | Sell |
290,513
-10,711
| -4% | -$684K | 0.16% | 110 |
|
|
2019
Q2 | $19.4M | Buy |
301,224
+14,894
| +5% | +$961K | 0.19% | 107 |
|
|
2019
Q1 | $18.2M | Sell |
286,330
-84,941
| -23% | -$4.46M | 0.2% | 92 |
|
|
2018
Q4 | $14.1M | Buy |
371,271
+23,426
| +7% | +$827K | 0.19% | 92 |
|
|
2018
Q3 | $14.9M | Sell |
347,845
-205,743
| -37% | -$7.19M | 0.17% | 95 |
|
|
2018
Q2 | $12.2M | Sell |
553,588
-352,389
| -39% | -$4.33M | 0.15% | 103 |
|
|
2018
Q1 | $4.49M | Buy |
905,977
+627,410
| +225% | +$2.02M | 0.06% | 158 |
|
|
2017
Q4 | $657K | Sell |
278,567
-35,591
| -11% | -$112K | 0.01% | 269 |
|
|
2017
Q3 | $2.29M | Sell |
314,158
-3,106
| -1% | -$19.7K | 0.03% | 227 |
|
|
2017
Q2 | $2.54M | Sell |
317,264
-50,464
| -14% | -$466K | 0.04% | 222 |
|
|
2017
Q1 | $4.41M | Buy |
367,728
+234,744
| +177% | +$5.13M | 0.07% | 182 |
|
|
2016
Q4 | $2.86M | Buy |
132,984
+14,168
| +12% | +$545K | 0.04% | 223 |
|
|
2016
Q3 | $9.1M | Sell |
118,816
-1,170
| -1% | -$85.3K | 0.14% | 136 |
|
|
2016
Q2 | $9.05M | Buy |
119,986
+2,103
| +2% | +$169K | 0.14% | 144 |
|
|
2016
Q1 | $10.1M | Buy |
117,883
+1,227
| +1% | +$107K | 0.15% | 136 |
|
|
2015
Q4 | $13.8M | Sell |
116,656
-1,020
| -0.9% | -$101K | 0.19% | 126 |
|
|
2015
Q3 | $10.4M | Sell |
117,676
-2,485
| -2% | -$289K | 0.14% | 158 |
|
|
2015
Q2 | $13M | Sell |
120,161
-19
| -0% | -$2.36K | 0.14% | 166 |
|
|
2015
Q1 | $15.2M | Buy |
120,180
+5,297
| +5% | +$689K | 0.16% | 143 |
|
|
2014
Q4 | $14.6M | Sell |
114,883
-515
| -0.4% | -$71.4K | 0.15% | 145 |
|
|
2014
Q3 | $15.5M | Buy |
115,398
+1,080
| +0.9% | +$151K | 0.16% | 147 |
|
|
2014
Q2 | $18.6M | Sell |
114,318
-1,657
| -1% | -$282K | 0.18% | 148 |
|
|
2014
Q1 | $25.6M | Sell |
115,975
-11,768
| -9% | -$3M | 0.25% | 125 |
|
|
2013
Q4 | $32.9M | Buy |
+127,743
| New | +$29.2M | 0.32% | 116 |
|
Other funds holding TNDM
CIP
EC
BCM
BG
Wasatch Advisors's TNDM Position: Q4 2022 in Review
Wasatch Advisors sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 241,295 shares — an estimated $11.5M sold.
Wasatch Advisors first reported a position in TNDM in Q4 2013 and held it in 36 quarters. The position peaked at $51.1M in Q4 2021. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.
- Wasatch Advisors reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
- Wasatch Advisors sold 241,295 Tandem Diabetes Care shares in Q4 2022, an estimated $11.5M.
- Wasatch Advisors first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 36 quarters.
- Wasatch Advisors's Tandem Diabetes Care position peaked at $51.1M in Q4 2021.
- 295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.
Based on Wasatch Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.